T1	PROC 46 66	Estudio de extensión
T2	PROC 75 86	seguimiento
#1	AnnotatorNotes T2	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T3	DISO 108 147	degeneración macular asociada a la edad
#2	AnnotatorNotes T3	C0242383; Age related macular degeneration; Disease or Syndrome
T4	PROC 174 289	ensayo clínico de fase IV-II distribuido al azar, enmascarado con tratamiento fingido sobre la eficacia y seguridad
T5	PROC 1000 1007	tratado
#3	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	CHEM 308 319	medicamento
#4	AnnotatorNotes T6	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T7	CHEM 321 331	etamsilato
#5	AnnotatorNotes T7	C0014968; ethamsylate; Organic Chemical · Pharmacologic Substance
T8	PROC 345 363	pinchazo en el ojo
T9	PROC 376 390	ensayo clínico
#6	AnnotatorNotes T9	C0008976; Clinical Trials; Research Activity
T10	PROC 434 454	Estudio de extensión
T11	PROC 463 474	seguimiento
#7	AnnotatorNotes T11	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T12	DISO 496 535	degeneración macular asociada a la edad
#8	AnnotatorNotes T12	C0242383; Age related macular degeneration; Disease or Syndrome
T13	CHEM 672 682	etamsilato
#9	AnnotatorNotes T13	C0014968; ethamsylate; Organic Chemical · Pharmacologic Substance
T14	DISO 747 786	Degeneración macular asociada a la edad
#10	AnnotatorNotes T14	C0242383; Age related macular degeneration; Disease or Syndrome
T15	DISO 813 852	Degeneración macular asociada a la edad
#11	AnnotatorNotes T15	C0242383; Age related macular degeneration; Disease or Syndrome
T16	DISO 854 858	DMAE
#12	AnnotatorNotes T16	C0242383; Age related macular degeneration; Disease or Syndrome
T17	PROC 929 940	tratamiento
#13	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	ANAT 996 999	ojo
#14	AnnotatorNotes T18	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T19	PROC 1015 1029	ensayo clínico
#15	AnnotatorNotes T19	C0008976; Clinical Trials; Research Activity
T20	PROC 1196 1220	Consentimiento Informado
#16	AnnotatorNotes T20	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T21	PROC 1156 1165	protocolo
#17	AnnotatorNotes T21	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T22	DISO 1264 1290	enfermedades concomitantes
#18	AnnotatorNotes T22	C0243087; concomitant disease; Pathologic Function
T23	DISO 1345 1355	enfermedad
#19	AnnotatorNotes T23	C0012634; Disease; Disease or Syndrome
T24	PROC 1370 1382	tratamientos
#20	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	DISO 1431 1435	DMAE
#21	AnnotatorNotes T25	C0242383; Age related macular degeneration; Disease or Syndrome
T26	DISO 1442 1459	diabetes mellitus
#22	AnnotatorNotes T26	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T27	ANAT 1475 1481	ocular
#23	AnnotatorNotes T27	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T28	DISO 1483 1502	infección sistémica
#24	AnnotatorNotes T28	C0243026; Sepsis; Disease or Syndrome
T29	DISO 1532 1548	infección ocular
T30	DISO 1550 1574	trastornos psiquiátricos
#25	AnnotatorNotes T30	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T31	ANAT 360 363	ojo
#26	AnnotatorNotes T31	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T32	PROC 562 668	ensayo clínico aleatorizado de fase IV-II controlado con tratamiento fingido sobre la eficacia y seguridad
T33	PROC 1054 1102	administración del tratamiento doble enmascarado
T34	DISO 1464 1481	afectación ocular
T35	ANAT 1542 1548	ocular
#27	AnnotatorNotes T35	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T36	Date 13 17	2015
T37	LIVB 94 103	pacientes
#28	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	LIVB 482 491	pacientes
#29	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Route 683 694	intravítreo
T40	LIVB 888 897	Pacientes
#30	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	DEVI 973 987	optotipo ETDRS
#31	AnnotatorNotes T41	C1275992; ETDRS visual acuity chart; Medical Device
T42	Date 1033 1045	la semana 16
T43	LIVB 1106 1115	Pacientes
#32	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T45	LIVB 1250 1259	Pacientes
#33	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 1309 1321	investigador
#34	AnnotatorNotes T46	C0035173; Research Personnel; Professional or Occupational Group
T49	LIVB 1671 1716	Mujeres embarazadas o en periodo de lactancia
#35	AnnotatorNotes T49	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T44	PHYS 1679 1690	embarazadas
#36	AnnotatorNotes T44	C0032961; Pregnancy; Organism Function
T47	PHYS 1707 1716	lactancia
#37	AnnotatorNotes T47	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T48	Date 1503 1511	en curso
#38	AnnotatorNotes T39	C1517572; Intravitreal Route of Drug Administration; Functional Concept
#39	AnnotatorNotes T33	C0013072; Double-Blind Method; Research Activity
#40	AnnotatorNotes T29	C0015403; Eye Infection; Disease or Syndrome 
T50	Spec_cue 1322 1328	puedan
T51	CONC 1329 1336	influir
A1	Assertion T51 Speculated
#41	AnnotatorNotes T51	C0521102; Interferes with; Functional Concept
T52	Spec_cue 1601 1607	puedan
T53	CONC 1608 1615	afectar
A2	Assertion T53 Speculated
#42	AnnotatorNotes T53	C0521102; Interferes with; Functional Concept
R1	Speculation Arg1:T50 Arg2:T51	
R2	Speculation Arg1:T52 Arg2:T53	
R3	Experiences Arg1:T37 Arg2:T3	
R4	Experiences Arg1:T37 Arg2:T6	
R5	Experiences Arg1:T37 Arg2:T7	
R6	Location_of Arg1:T31 Arg2:T8	
R7	Used_for Arg1:T6 Arg2:T8	
R8	Used_for Arg1:T7 Arg2:T8	
R9	Experiences Arg1:T37 Arg2:T8	
R10	Experiences Arg1:T38 Arg2:T12	
R11	Experiences Arg1:T38 Arg2:T13	
R12	Has_Route_or_Mode Arg1:T13 Arg2:T39	
T54	Observation 916 940	respuesta al tratamiento
#43	AnnotatorNotes T54	C1319171; Medication response; Finding
R14	Experiences Arg1:T40 Arg2:T17	
R15	Experiences Arg1:T40 Arg2:T41	
R16	Experiences Arg1:T40 Arg2:T5	
R17	Location_of Arg1:T18 Arg2:T5	
R18	Location_of Arg1:T18 Arg2:T17	
R19	Overlap Arg1:T5 Arg2:T42	
R20	Overlap Arg1:T54 Arg2:T42	
R21	After Arg1:T54 Arg2:T33	
R22	Experiences Arg1:T40 Arg2:T33	
R23	Overlap Arg1:T17 Arg2:T54	
T55	Observation 1120 1165	capacidad y voluntad para seguir el protocolo
R25	Before Arg1:T20 Arg2:T21	
R26	Experiences Arg1:T45 Arg2:T22	
R27	Experiences Arg1:T45 Arg2:T23	
R30	Experiences Arg1:T45 Arg2:T24	
R31	Overlap Arg1:T22 Arg2:T25	
R32	Overlap Arg1:T23 Arg2:T25	
R33	Overlap Arg1:T25 Arg2:T26	
R34	Location_of Arg1:T27 Arg2:T34	
R35	Experiences Arg1:T45 Arg2:T25	
R36	Experiences Arg1:T45 Arg2:T26	
R37	Experiences Arg1:T45 Arg2:T34	
R38	Experiences Arg1:T45 Arg2:T28	
R39	Experiences Arg1:T45 Arg2:T29	
R40	Experiences Arg1:T45 Arg2:T30	
R41	Experiences Arg1:T49 Arg2:T44	
R42	Experiences Arg1:T49 Arg2:T47	
R43	Location_of Arg1:T35 Arg2:T29	
R44	Overlap Arg1:T25 Arg2:T34	
R45	Overlap Arg1:T25 Arg2:T28	
R46	Overlap Arg1:T28 Arg2:T48	
R47	Overlap Arg1:T25 Arg2:T29	
R48	Overlap Arg1:T25 Arg2:T30	
T56	Quantifier_or_Qualifier 1514 1520	activa
#44	AnnotatorNotes T56	C0679217; Active State; Idea or Concept
R49	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T56	
T57	Observation 1576 1631	situaciones sociales que puedan afectar al cumplimiento
R50	Before Arg1:T57 Arg2:T53	
#45	AnnotatorNotes T34	C0262477; Eye problem; Finding (?)
R13	Overlap Arg1:T25 Arg2:T57	
#46	AnnotatorNotes T48	C0521116; Current (present time); Temporal Concept
#47	AnnotatorNotes T8	C2069457; Intravitreal injection of pharmacologic agent; Therapeutic or Preventive Procedure (?)
A3	Experiencer T40 Patient
A4	Experiencer T37 Patient
A5	Experiencer T38 Patient
A6	Experiencer T43 Patient
A7	Experiencer T45 Patient
A8	Experiencer T46 Other
A9	Experiencer T49 Patient
